{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:21:35Z","timestamp":1790346095478,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/Z516405\/1"],"award-info":[{"award-number":["BB\/Z516405\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/S008098\/1"],"award-info":[{"award-number":["BB\/S008098\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015272","name":"Societ\u00e0 Italiana di Farmacologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y014707\/1"],"award-info":[{"award-number":["MR\/Y014707\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/T032669\/1"],"award-info":[{"award-number":["MR\/T032669\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P009824\/2"],"award-info":[{"award-number":["MR\/P009824\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.molmet.2025.102214","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:27:58Z","timestamp":1752679678000},"page":"102214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight"],"prefix":"10.1016","volume":"99","author":[{"given":"Claire H.","family":"Feetham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minrong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Culotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Emmerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Luckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2025.102214_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The discovery and development of liraglutide and semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.molmet.2025.102214_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(18)30024-X","article-title":"Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial","volume":"6","author":"Pratley","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.molmet.2025.102214_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabet.2018.12.001","article-title":"Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: insights from the SUSTAIN 1-7 trials","volume":"45","author":"Aroda","year":"2019","journal-title":"Diabetes Metab"},{"issue":"9","key":"10.1016\/j.molmet.2025.102214_bib4","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/dom.13353","article-title":"Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials","volume":"20","author":"Ahren","year":"2018","journal-title":"Diabetes Obes Metabol"},{"issue":"12","key":"10.1016\/j.molmet.2025.102214_bib5","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-8587(16)30263-7","article-title":"GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?","volume":"4","author":"Nauck","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.molmet.2025.102214_bib6","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or besity","volume":"384","author":"Wilding","year":"2021","journal-title":"Reply N Engl J Med"},{"issue":"209","key":"10.1016\/j.molmet.2025.102214_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci Transl Med"},{"issue":"10160","key":"10.1016\/j.molmet.2025.102214_bib8","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.molmet.2025.102214_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Frias","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.molmet.2025.102214_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","article-title":"GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications","volume":"35","author":"Campbell","year":"2023","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.molmet.2025.102214_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.molmet.2025.102214_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55164","article-title":"The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling","volume":"9","author":"Worth","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.molmet.2025.102214_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101407","article-title":"Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation","volume":"55","author":"Costa","year":"2022","journal-title":"Mol Metabol"},{"issue":"11","key":"10.1016\/j.molmet.2025.102214_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110953","article-title":"A brainstem circuit for nausea suppression","volume":"39","author":"Zhang","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.molmet.2025.102214_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","article-title":"LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept","volume":"18","author":"Coskun","year":"2018","journal-title":"Mol Metabol"},{"issue":"12","key":"10.1016\/j.molmet.2025.102214_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146353","article-title":"GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in Obese mice","volume":"131","author":"Samms","year":"2021","journal-title":"J Clin Investig"},{"issue":"17","key":"10.1016\/j.molmet.2025.102214_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.molmet.2025.102214_bib18","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/dom.15216","article-title":"The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide","volume":"25","author":"Gasbjerg","year":"2023","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2025.102214_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/jc.2002-021053","article-title":"Similar elimination rates of glucagon-like peptide-1 in Obese type 2 diabetic patients and healthy subjects","volume":"88","author":"Vilsboll","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.molmet.2025.102214_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28496-6","article-title":"Integrated brain atlas for unbiased mapping of nervous system effects following liraglutide treatment","volume":"8","author":"Salinas","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.molmet.2025.102214_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.molmet.2025.102214_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41467-020-14309-w","article-title":"Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics","volume":"11","author":"Ast","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.molmet.2025.102214_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s42255-021-00344-4","article-title":"Central and peripheral GLP-1 systems independently suppress eating","volume":"3","author":"Brierley","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102214_bib24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-024-07685-6","article-title":"Dissociable hindbrain GLP1R circuits for satiety and aversion","volume":"632","author":"Huang","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2025.102214_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54367-y","article-title":"Brainstem BDNF neurons are downstream of GFRAL\/GLP1R signalling","volume":"15","author":"Feetham","year":"2024","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.molmet.2025.102214_bib26","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1210\/endo.133.6.8243312","article-title":"Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain","volume":"133","author":"Usdin","year":"1993","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.molmet.2025.102214_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0196-9781(94)90016-7","article-title":"Gastric inhibitory polypeptide (GIP) binding sites in rat brain","volume":"15","author":"Kaplan","year":"1994","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.molmet.2025.102214_bib28","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","article-title":"Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake","volume":"30","author":"Adriaenssens","year":"2019","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.molmet.2025.102214_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164921","article-title":"Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding","volume":"8","author":"Adriaenssens","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.molmet.2025.102214_bib30","article-title":"Brainstem peptides and peptidergic neurons in the regulation of appetite","volume":"24","author":"D'Agostino","year":"2022","journal-title":"Curr Op Endocr Metab Res"},{"issue":"4","key":"10.1016\/j.molmet.2025.102214_bib31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s42255-021-00363-1","article-title":"A genetic map of the mouse dorsal vagal complex and its role in obesity","volume":"3","author":"Ludwig","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102214_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101240","article-title":"A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing","volume":"53","author":"Dowsett","year":"2021","journal-title":"Mol Metabol"},{"issue":"3","key":"10.1016\/j.molmet.2025.102214_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.neuron.2020.11.010","article-title":"Area postrema cell types that mediate nausea-associated behaviors","volume":"109","author":"Zhang","year":"2021","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.molmet.2025.102214_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021357118","article-title":"GFRAL-Expressing neurons suppress food intake via aversive pathways","volume":"118","author":"Sabatini","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.molmet.2025.102214_bib35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmet.2021.01.015","article-title":"The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/j.molmet.2025.102214_bib36","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s42255-023-00931-7","article-title":"Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice","volume":"5","author":"Liskiewicz","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.molmet.2025.102214_bib37","article-title":"Specific loss of GIPR signaling in GABAergic neurons enhances GLP-1R agonist-induced body weight loss","volume":"95","author":"Wean","year":"2024","journal-title":"Mol Metabol"},{"issue":"6","key":"10.1016\/j.molmet.2025.102214_bib38","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.cmet.2014.04.005","article-title":"The role of \u03b2 cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs","volume":"19","author":"Smith","year":"2014","journal-title":"Cell Metab"},{"issue":"13","key":"10.1016\/j.molmet.2025.102214_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116506119","article-title":"Structural determinants of dual incretin receptor agonism by tirzepatide","volume":"119","author":"Sun","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.molmet.2025.102214_bib40","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.cmet.2024.05.010","article-title":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2025.102214_bib41","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12225","article-title":"Appetite controlled by a cholecystokinin nucleus of the solitary tract to hypothalamus neurocircuit","volume":"5","author":"D'Agostino","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.molmet.2025.102214_bib42","series-title":"The mouse brain","author":"Paxinos","year":"2001"},{"issue":"4","key":"10.1016\/j.molmet.2025.102214_bib43","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2014.10.010","article-title":"iDISCO: a simple, rapid method to immunolabel large tissue samples for volume imaging","volume":"159","author":"Renier","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.molmet.2025.102214_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1172\/JCI0215595","article-title":"Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons","volume":"110","author":"Yamamoto","year":"2002","journal-title":"J Clin Investig"},{"key":"10.1016\/j.molmet.2025.102214_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114236","article-title":"Metabolic hormone action in the VTA: reward-Directed behavior and mechanistic insights","volume":"268","author":"Geisler","year":"2023","journal-title":"Physiol Behav"},{"issue":"6","key":"10.1016\/j.molmet.2025.102214_bib46","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.neuron.2017.02.034","article-title":"Basolateral to central amygdala neural circuits for appetitive behaviors","volume":"93","author":"Kim","year":"2017","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.molmet.2025.102214_bib47","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nn.4623","article-title":"Central amygdala circuits modulate food consumption through a positive-valence mechanism","volume":"20","author":"Douglass","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.molmet.2025.102214_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101443","article-title":"Dissecting a disynaptic central amygdala-parasubthalamic nucleus neural circuit that mediates cholecystokinin-induced eating suppression","volume":"58","author":"Sanchez","year":"2022","journal-title":"Mol Metabol"},{"key":"10.1016\/j.molmet.2025.102214_bib49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature12596","article-title":"Genetic identification of a neural circuit that suppresses appetite","volume":"503","author":"Carter","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.molmet.2025.102214_bib50","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1038\/npp.2014.74","article-title":"Glucagon-like peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed","volume":"39","author":"Alhadeff","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmet.2025.102214_bib51","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuroscience.2017.06.049","article-title":"A tale of two circuits: CCK(NTS) neuron stimulation controls appetite and induces opposing motivational states by projections to distinct brain regions","volume":"358","author":"Roman","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.molmet.2025.102214_bib52","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1523\/JNEUROSCI.1466-19.2019","article-title":"Manipulations of central amygdala neurotensin neurons alter the consumption of ethanol and sweet fluids in mice","volume":"40","author":"Torruella-Suarez","year":"2020","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.molmet.2025.102214_bib53","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"Veniant","year":"2024","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.molmet.2025.102214_bib54","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s42255-025-01295-w","article-title":"GIPR-Ab\/GLP-1 peptide-antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in Obese mice","volume":"7","author":"Liu","year":"2025","journal-title":"Nat Metab"},{"issue":"6","key":"10.1016\/j.molmet.2025.102214_bib55","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s42255-025-01294-x","article-title":"GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male mice","volume":"7","author":"Gutgesell","year":"2025","journal-title":"Nat Metab"},{"issue":"2","key":"10.1016\/j.molmet.2025.102214_bib56","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0306-4522(96)00076-0","article-title":"Induction of members of the Fos\/Jun family of immediate-early genes in identified hypothalamic neurons: in vivo evidence for differential regulation","volume":"73","author":"Luckman","year":"1996","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.molmet.2025.102214_bib57","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuron.2013.03.025","article-title":"Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations","volume":"78","author":"Guenthner","year":"2013","journal-title":"Neuron"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T15:16:26Z","timestamp":1755098186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877825001218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":57,"alternative-id":["S2212877825001218"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102214","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downstream interaction by glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonism is required for synergistic effects on body weight","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102214"}}